Induction of chemosensitivity in nasopharyngeal carcinoma cells using a human papillomavirus regulatory sequence and the thymidine kinase gene

Journal of Biomedical Science

Volumn 9, Issue 1, 2002, Pages 41-46

  Chow, Kai Ping N ^a   Lu, Hsi Chi ^c   Chou, Huar Fen ^e   Liu, Hao Ping ^a   Hsieh, Shie Liang ^d   Chang, Yu Sun ^a,b   Choo, Kong Bung ^e  

^a Medical College   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Gene therapy; Human papillomavirus; Nasopharyngeal carcinoma; Prodrug treatment; Thymidine kinase

Indexed keywords

BETA GALACTOSIDASE; GANCICLOVIR; RECOMBINANT DNA; THYMIDINE KINASE; VIRUS VECTOR;

ANIMAL MODEL; ARTICLE; BODY WEIGHT; CARCINOMA CELL; CELL DEATH; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; FEASIBILITY STUDY; GENE CONSTRUCT; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; MORTALITY; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; NUDE MOUSE; PAPILLOMA VIRUS; PRIORITY JOURNAL; REGULATORY SEQUENCE; TUMOR GROWTH; TUMOR VOLUME; VIRUS RECOMBINANT;

ANIMALS; ANTIVIRAL AGENTS; CELL DEATH; CRICETINAE; DNA, VIRAL; FEASIBILITY STUDIES; GANCICLOVIR; HUMANS; MICE; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PRODRUGS; REGULATORY SEQUENCES, NUCLEIC ACID; THYMIDINE KINASE; TRANSFECTION; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

HUMAN HERPESVIRUS 4; HUMAN PAPILLOMAVIRUS; MUS MUSCULUS; PAPILLOMAVIRUS;

EID: 0036164696     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000048198     Document Type: Article

References (35)

1. Ovarian cancer gene therapy: Repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model
2. Thymidine kinase-mediated killing of rat brain tumors
3. Cloning and characterization of the latent membrane protein of a specific Epstein-Barr virus variant derived from nasopharyngeal carcinoma in the Taiwanese population
4. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
5. Nasopharyngeal carcinoma. X. Presence of Epstein-Barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya
6. Heterogeneity of the human papillomavirus group
7. The 'bystander effect': Tumor regression when a fraction of the tumor mass is genetically modified
8. Tumor regression when a fraction of tumor mass contains the HSV-TK gene
9. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers
10. Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, non-immunogenic tumor cell vaccines
11. Methylation of single sites within the herpes simplex virus tk-coding region and the simian virus 40 T-antigen intron causes gene inaction
12. Molecular and serological studies of human papillomavirus among patients with anal epidermoid carcinoma
13. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma
14. Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active cases with long-term survivors
15. Nasopharyngeal cancer in Taiwan. Clinical manifestations and results of therapy
16. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line
17. The role of Epstein-Barr virus in neoplastic transformation
18. Encapsidation of adeno-associated virus type 2 Rep proteins in wild type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells
19. Establishment and characterization of two nasopharyngeal carcinoma cell lines
20. Presence of Epstein-Barr virus latent membrane protein 1 gene in the nasopharyngeal swabs from patients with nasopharyngeal carcinoma
21. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
22. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration
23. Homology of Epstein-Barr virus DNA in nasopharyngeal carcinomas from Kenya, Taiwan, Singapore and Tunisia
24. Presence of HPV 16 sequences in laryngeal carcinomas
25. Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes
26. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats
27. The tumor suppressive properties of adeno-associated viruses
28. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology
29. The expression of papillomaviruses in epithelial cells
30. Gene therapy of malignant brain tumors: A rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells
31. Detection of Epstein-Barr virus and human papillomavirus in head and neck tumors
32. Transcriptional activation of NF-κB activity by Epstein-Barr virus (EBV) LMP1 as a selective therapeutic strategy for EBV-associated diseases
33. Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro
34. Limitations of retrovirus-mediated HSV-tk gene transfer to pulmonary adenocarcinoma cells in vitro and in vivo
35. Viruses in human cancers